Results 251 to 260 of about 221,321 (383)
Psychiatric Disorders: Neurotransmitter and Neuropeptides. (Progress in Brain Research Volume 65.) [PDF]
P Jenner
openalex +1 more source
Central mechanisms of emesis: A role for GDF15
Abstract Background Nausea and emesis are ubiquitously reported medical conditions and often present as treatment side effects along with polymorbidities contributing to detrimental life‐threatening outcomes, such as poor nutrition, lower quality of life, and unfavorable patient prognosis.
Tito Borner+2 more
wiley +1 more source
Cell-specific tools for understanding behavior. [PDF]
Holder BL, Dissel S.
europepmc +1 more source
Isolation of pheromone biosynthesis activating neuropeptide of the silkworm, Bombyx mori.
Hiromichi Nagasawa+8 more
openalex +2 more sources
Evidence‐based review and frontiers of migraine therapy
Abstract Background Cyclic vomiting syndrome (CVS) is identified as one of the “episodic syndromes that may be associated with migraine,” along with benign paroxysmal torticollis, benign paroxysmal vertigo, and abdominal migraine. It has been proposed that CVS and migraine may share pathophysiologic mechanisms of hypothalamic activation and altered ...
Kaitlin A. Greene+2 more
wiley +1 more source
The effect of quercetin on obesity and reproduction through the expression of genes involved in the hypothalamus-pituitary-gonadal axis. [PDF]
Shams E+7 more
europepmc +1 more source
Endocannabinoid signaling in stress, nausea, and vomiting
Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono+2 more
wiley +1 more source